To orchestrate context-dependent signaling programs poxviruses encode two dual-specificity enzymes, the F10 kinase and the H1 phosphatase. These signaling mediators are essential for poxvirus production, yet their substrate profiles and systems level functions remain enigmatic. Using a phosphoproteomic screen of cells infected with wildtype, F10, and H1 mutant viruses we systematically defined the viral signaling network controlled by these enzymes. Quantitative cross-comparison revealed 33 F10 and/or H1 phosphosites within 17 viral proteins. Using this proteotype dataset to inform genotype-phenotype relationships we found that H1-deficient virions harbor a hidden hyper-cleavage phenotype driven by reversible phosphorylation of the virus protease I7 (S134).
Introduction
As a reversible post-translational modification, phosphorylation plays an indispensable role in many fundamental cellular processes. In recent years it has become increasingly clear that dynamic phosphorylation also serves to regulate the replicative cycle of many viruses 1 . Advances in quantitative mass spectrometry based phosphoproteomic technology enable the interrogation of complex signaling networks including viral phosphorylation networks [2] [3] [4] . Yet for most, a systems level understanding of viral phospho-networks and how they drive infection phenotypes and assure virion infectivity is lacking. Filling this gap in our molecular understanding of signaling networks provides an unprecedented opportunity to bridge our current understanding of genotype-phenotype relationships using proteotype information.
Vaccinia virus (VACV) is the prototype member of the Poxviridae , a family of large dsDNA viruses that include variola virus, the causative agent of smallpox 5 . Poxviruses are among the largest and most complex mammalian viruses producing infectious mature virions (MVs) containing~80 different viral proteins 6, 7 . Assembly of these virions occurs exclusively in the cytoplasm of infected cells proceeding through several morphologically distinct stages reviewed in elswhere 5, 8 ).
Results

Defining the F10/H1 phosphoproteome
In order to define the viral phospho-signaling network regulated by F10 kinase and/or H1 phosphatase we infected HeLa cells with either VACV WT, inducible F10 [VACV vF10V5i referred to as F10 (-)] or H1 [VACV v ind H1 referred as H1(-)] recombinants in which expression of these enzymes has been repressed 19, 23 (Fig. 1A ). Uninfected cells served as controls for these experiments. Cells were harvested 12 hours post infection (h.p.i.), a time in which intermediate and late viral genes are maximally expressed 5, 24 .
Proteins were subjected to tryptic digestion followed by phosphopeptide enrichment on TiO 2 beads. Phosphopeptides were analyzed by LC-MS/MS and quantified across conditions.
We identified 105 non-redundant serine (S), threonine (T), and tyrosine (Y) phosphorylation sites in 43 viral proteins (Table S1 ). Relative quantification of the WT, H1(-), and F10(-) phospho-enriched samples revealed 28 unique F10-dependent phosphosites in 14 viral proteins, 21 unique H1-dependent phosphosites in 13 viral proteins, and 16 unique phosphorylation sites in 10 viral proteins whose phosphorylation was regulated in an F10 and H1 dependent fashion ( Fig. 1B ; green and purple boxes).
Amongst the 10 F10/H1 shared substrates, 8 phosphosites were identified on 4 known shared substrates: S85 of A14, S235 of A4, S32, S167 and S197 of A17, and S229 and S261 of G7 8, 19, 20, 25, 26 . We also identified 8 novel phosphorylation sites on 6 unknown shared substrates: A12, A19, G3, H5, F17, and I7 ( Fig. 1B ; green and purple boxes).
Amongst the F10/H1 substrates identified, two membrane proteins (A14, A17), 5 core proteins (A19, A4, A12, G7, H5), the lateral body protein F17, and the I7 protease, are each essential for proper VACV assembly 8 . These results suggested to us that the phenotypic defects observed upon complete loss of these various proteins may be masking underlying proteotype information about the critical role of the F10/H1 signaling network for virus assembly.
Proteotype profiling of phosphatase-deficient VACV virions
In many cases, phenotypic outcomes can be best described by the underlying proteotype; the acute state of the proteome under given constraints 27 . We detected many quantitative changes in the VACV phospho-proteotype in the absence of F10 or H1 in infected cells ( Fig. 1B) . To determine if these changes are reflected in the virion proteotype we undertook a comparative proteomic analysis of WT and H1(-) MVs at the protein level. As F10 is essential for VACV morphogenesis, virions cannot be produced in its absence 10 . In total, 139 viral proteins were identified and quantified between WT and H1(-) MVs (Fig. 1C and Table S2 ). Amongst these, 48 were found to be less abundant by more than twofold in H1(-) than in WT MVs, including H1 which was 43-fold less abundant. Interestingly, the EV specific proteins A33, A34, A56, B5 and F13
(reviewed in 28 ) are significantly depleted in purified virions produced in the absence of H1 (Fig. 1C, underlined label) , hinting that production of EVs may be hindered. In contrast, the MV specific proteins A25 and A26 do not change abundance between H1(-) and WT MVs ( Fig 1C, dashed underlined label) 29 . This suggests, in line with previous reports 19 , that there is no defect in MV production in the absence of H1. As the vast majority of virions produced are MVs 5 and we didn't observe striking changes in protein abundance between WT and H1(-) MVs, we reason that the F10/H1 viral phospho-signaling network is not controlling the protein copy number required for assembly of progeny virions.
We next compared the phospho-proteotype of WT and H1(-) MVs. Quantitative phosphoproteomics analysis after TiO2 phosphopeptide enrichment yielded 179 phosphosites on 47 viral proteins (Fig. 1D ). The phosphosites were exclusively serines (78.6%) and threonines (21.4% T), from which 62 were hyperphosphorylated and 37 hypophosphorylated in H1(-) MVs (Fig. 1D , Table S3 ). Of the 17 viral phosphoproteins comprising the F10/H1 phospho-signaling network found in infected cells ( Fig. 1B , Table   S1 ), only G3L was non-phosphorylated in MVs ( Fig. 1D , Table S3 ). Among the 21 unique H1 phosphosites identified in cells ( Fig 1B, purple squares), 15 were found to be hyperphosphorylated in H1(-) MVs. Of note, F10 and I7 protease another key enzyme essential for the formation of MVs, were among these H1 substrates ( Fig. 1B and 1D ).
Dynamic phosphorylation of I7 is required for proteolytic processing and virus production
That proteotype analysis revealed F10 and I7 as H1 substrates raised the possibility that in addition to the transcription-negative phenotype of H1(-) virions, the phosphatase also facilitates the formation of progeny virions. The phosphorylation of F10 at S7/8 or Y11
was recently reported, yet its link to H1 and the importance of these modifications was not investigated 30 . To address the functional relevance of these modifications we complemented an F10 mutant virus ( Cts 28) with HA-F10 as well as HA-F10 phosphomimetic and phosphodeletion mutants. These proteins each rescued virus yield to the same level, suggesting that dynamic phosphorylation of F10 S7/8 or Y11 plays no role in virus assembly ( Supplementary Fig. 1A and B ).
We next turned to the I7 protease, the enzyme essential for virion maturation through proteolytic cleavage of core and membrane proteins 11, 15, 31 . Our phospoproteomics results indicated that I7 is phosphorylated on S134 in an F10 and H1 dependent fashion ( Fig.   1B ). Though distant on the primary structure from the putative catalytic triad H241, D248, C328 11, 15, 31 , we hypothesized that F10/H1-mediated dynamic phosphorylation of S134 may regulate I7 protease activity. To test this we applied transient complementation assays using a VACV mutant harboring a temperature-sensitive version of I7 , Cts16 12, 32 .
This virus has a stringent phenotype, displaying a 4'000-fold reduction in 24 h viral yield when grown at 40.0 ° C rather than the permissive 31.0 ° C. While virus production could be complemented by 2-logs using a C-terminal HA-tagged version of WT I7 (I7-HA), neither the phosphodeletion-(I7-HA S134A), nor the phosphomimetic-(I7-HA S134E) mutants could rescue virus yield ( Fig. 2A ). Comparable amounts of WT and mutant proteins were expressed assuring that the inability to rescue was not due to instability of the mutants ( Fig. 2A ; inset). Next we analyzed the I7-dependent cleavage of the major core protein(P4a) and the membrane protein (A17) both I7 substrates required for virion maturation (refs). While complementation with WT I7-HA rescued cleavage of both, I7-HA S134A and S134E mutants were unable to complement the loss of I7 ( Fig. 2B ).
Collectively, these results strongly suggest that F10/H1-mediated dynamic phosphorylation of I7 at S134 is required for its protease activity.
H1 regulates intra-virion I7 protease activity
Our H1(-) virion proteotype profiling indicated that the abundance of I7 was unchanged at the protein level but its phosphorylation on S134 was increased by 35-fold compared to WT MVs (Fig. 1D ). That the H1(-) mutant virus does not phenocopy the assembly defect seen in the absence of I7 33 reasons that F10 phosphorylation of S134 serves to activate, and dephosphorylation by H1 to inactivate, I7 proteinase activity. If correct, we would expect to see hyper-cleavage of I7 substrates in the absence of H1's phosphatase activity. To investigate this we infected cells with H1(-) mutant virus in the absence or presence of inducer (-/+ IPTG) and assessed the cleavage of p4a within cell lysates over time ( Fig. 2C ). No major difference in cleavage kinetics or efficiency was detected between the two samples.
However, the proteolytic processing of VACV core and membrane proteins by I7 occurs during the transformation of virions from immature (IVs) to mature (MVs) 11 15 . Thus the vast majority of I7 maturation-associated cleavage events occur within virions. Cleavage occurs at a conserved AG↓X motif found in 6 viral proteins: 5 core (p4a (A10), p4b (A3), G7, A12, and L4, and 1 membrane (A17) 15, 20, [34] [35] [36] [37] [38] . Our MV proteotype data indicated that the abundance of these proteins within virions, with the exception of A17, was largely independent of H1 expression and thus I7 hyperphosphorylation (Fig. 1C ). Taking advantage of the relatively low complexity of VACV MVs we performed a system-wide quantitative comparison of I7 substrate peptide distribution between WT and H1(-) MVs.
We found that single and consecutive tryptic peptides in the majority of I7 substrates showed significant changes in abundance between WT and H1(-) MVs ( Cleavage of A17 at position 16 serves to release the IV scaffolding protein D13 during the IV to MV transition [39] [40] [41] . Consistent with N-terminal hyper-cleavage of A17 in H1(-) virions, D13 was found to be 5.8-fold less abundant in these MVs (Fig. 1C ). In confirmation of these findings, immunoblot analyses of p4a, p4b, and A17 in purified WT and H1(-) virions indicates that each of these proteins is hyper-cleaved in the absence of H1 activity ( Fig. 2E ). That this was not detected in H1(-) cell lysates suggests that H1-mediated regulation of I7 activity is a strictly intra-virion event. To assess if hypercleavage correlated with any changes in virion structure, cytoplasmic H1(-) and H1(+) virions were compared by transmission electron microscopy (TEM) ( Supplementary Fig. 2 ). No obvious morphological differences were detected between the two samples. Thus the hypercleavage of VACV protein in H1(-) MVs is not detectable in the phenotype of H1(-) infections or the morphology of H1(-) virions. Only through proteotype profiling of these virions did we uncover an essential role for F10/H1 mediated dynamic phosphorylation of I7 in controlling the proteolytic processing of core and membrane proteins.
Viral early transcription proteins are hyperphosphorylated in H1(-) virions
We next asked if it was possible to use proteotype profiling to define the underlying cause of a mutant phenotype. As stated, the phenotype of the H1(-) mutant virus is the production of transcriptionally incompetent virions 19 . However, molecular understanding of this phenotype remains undefined. A comparison of WT and H1(-) MV proteomes showed no significant differences in the composition or abundance of core or accessory early transcription machinery (Fig. 1C , green and purple dots). This indicated that the H1(-) phenotype was not due to quantitative differences in transcription machinery packaging. Additional analyses of the transcription proteins indicated that none of those that contain AG↓X sites were cleaved in H1(-) MVs ( Supplementary Fig. 3 ), few were phosphorylated on serine or threonine, and none subject to H1 regulation ( Fig. 1D , Table S3 ). As H1 is a dual specificity enzyme capable of dephosphorylating tyrosines as well 19, 21 , we analyzed tyrosine phosphorylation of proteins in WT and H1(-) virions 21, 22, 30 .
For this 5mg of virions were purified and phosphotyrosine-containing peptides enriched by immunoprecipitation followed by LC-MS-MS analysis. This led to the identification and quantification of 29 phosphotyrosine sites on 18 viral proteins present in both WT and H1(-) MVs (Fig. 3A ). Amongst these, three components of the viral early transcription machinery were found to be hyper-phosphorylated in H1(-) virions: the RNA helicase NPH-II (I8) on Y634, L3 on Y89/Y90, and the viral early transcription factor (VETF) subunit A7 on Y367 ( Fig. 3A ; red bars) [42] [43] [44] [45] [46] .
Dynamic phosphorylation of A7 is required for infectious virus formation
The identification of four novel H1-regulated phosphotyrosines on three components of the transcription machinery provides the first potential link between the proteotype and transcription-deficient phenotype of H1(-) MVs 19 . To address the functional relevance of these tyrosine phosphosites we employed transient complementation as described above for F10 and I7. Wildtype HA-tagged versions of I8, L3, and A7 and there corresponding phospho-deletion and phospho-mimetic mutants were tested for their ability to complement non-permissive infections with viruses encoding inducible or ts versions of the corresponding proteins. For L3, we found that L3-HA was expressed but could not complement infectious virus production under non-permissive conditions in vL3Li-infected cells 36 Supplementary Fig. 4D ). These results indicated that dynamic phosphorylation of Y634 of I8 is not required for early viral transcription. Next, we tested the ability of A7-HA to rescue non-permissive viA7 infections 47 . Transient complementation showed that A7-HA was expressed and could rescue infection by 2-logs ( Fig. 3B ; pBSIIK A7-HA -dox). Transient complementation using either phosphodeletion (Y367A) or phosphomimetic (Y367E) versions of A7-HA failed to rescue infection despite being expressed to the level of WT A7-HA ( Fig. 3B ). These results indicate that dynamic phosphorylation of Y367 is required for A7 function and infectious virus production.
A7 phosphomutants phenocopy transcription deficient H1(-) virions
If the transcriptional deficiency of H1(-) virions is due to the inability to regulate dynamic phosphorylation of A7 Y367, one might expect the phenotypes of A7 phosphomutants and H1 deletion viruses to be the same. We first examined plaque morphology, as H1(-)
virions display a small plaque phenotype linked to their transcriptional defect 19 . Plaques Interestingly, the small plaque phenotype of the A7 phosphomutant virions was highly reminiscent of that seen upon repression of H1, rather than the abrogated plaque formation seen upon repression of A7. It reasons that the altered proteotype of these virions results in a transcriptional defect, rather than the assembly defect seen upon complete loss of A7 44, 47, 48 . To differentiate between these phenotypes we constructed a viA7L virus that expresses the core protein A4 as an mCherry fusion. This virus, viA7L mCherry-A4, is inducible for A7, contains a fluorescent core, and expresses gpt-EGFP from an early-late promoter 47 . Cells were infected with viA7L mCherry-A4 virus and transfected with A7-HA or the Y367A or Y367E A7 mutants. Infected cells (gpt-EGFP) expressing the various A7-HA plasmids were analyzed for MV formation using mCherry-A4 as a marker (Fig. 4A ). In the absence of inducer no discernable virion structures were formed confirming the requirement of A7 for morphogenesis ( Fig 4C ). In sum, using proteotype analyses we found that the large VETF subunit A7 is hyperphosphorylated on Y367 in H1(-) virions. Transient complementation showed that mutation of Y367 can bypass the MV assembly defect seen in the absence of A7 resulting in the formation of non-infectious virions that phenocopy H1(-) MVs.
Discussion
In eukaryotic cells, reversible protein phosphorylation is a well-established mechanism for the regulation of protein function. There are 518 kinases and 226 phosphatases in the human genome 49, 50 . This diversity can hamper identification of substrates and the investigation of how underlying proteotypes impact genotype-phenotype relationships.
Recent phosphoproteomic studies suggest that viruses, similar to eukaryotic cells, may use phosphorylation to modulate protein function 30, 51, 52 . Due to their relative simplicity, lack of redundancy, and genetic manipulability viruses offer an outstanding tool to probe proteotype/phenotype/genotype relationships.
Revealing the F10/H1 viral signaling network
Taking advantage of this we set out to define the VACV F10/H1 signaling network using proteomic profiling coupled with mutant viruses. The data set presented is the largest intrinsic virus signaling network uncovered to date. Consistent with other studies 30, 53 sequence alignment of 15 unambiguous sites provided no clear consensus for F10 or H1 substrate recognition ( Supplementary Fig. 5 ), suggesting that other (e.g. structural)
features are required for this. None-the-less these results uncovered 21 H1-dependent phosphosites within 13 substrate proteins required for virus membrane assembly, virion maturation, proteolytic processing, and potentially virion egress (Table S4 ). Highlighting the power of proteotype analyses, these results indicate that the F10/H1 signaling network regulates aspects of the VACV lifecycle in addition to those revealed by the phenotypes of the respective mutant viruses.
Dynamic phosphorylation of I7 and VACV maturation
While genetic recombinant viral mutants serve as powerful tools to assess the requirement of a particular protein, their phenotype always reflects the first temporal block in the lifecycle of a virus. This makes it nearly impossible to define additional phenotypes that underlie the loss of a particular protein. Using quantitative phosphoproteomics in WT, F10(-) and H1(-) infected cell lysates we show it is possible to uncover these masked phenotypes. We found that the viral protease I7 is a F10/H1
substrate. Further proteotype profiling of WT and H1(-) virions uncovered an I7 substrate hypercleavage phenotype underlying the transcription defect of H1(-) virions. As this phenotype was detected in purified virions but not infected cell lysates we suspect that H1-mediated phosphoregulation of I7 activity occurs within virions in a temporally or spatially controlled fashion in which the differential sub-virion localization of F10 13 and H1 54 reflects the need to partition their activities for successful I7 phosphoregulated virion maturation.
H1(-) MV proteotype and transcriptional defect
Phosphoproteotype analysis of WT and H1(-) MVs revealed three early transcription proteins hyperphosphorylated on tyrosine residues in the absence of H1 ( Fig. 3A and Supplementary Table 3 ). Amongst these, dynamic phosphorylation of Y367 of A7, the large subunit of the VACV VETF, was found to be required for productive virus infection ( Fig. 3B ). While A7 packaging appears to act as an assembly checkpoint 53, 55, 56 , phospho-deletion and phospho-mimetic mutants bypass this assembly block and form
MVs that produce small plaques that phenocopy the plaque formation defect of H1(-) virions 19 . Thus it reasons that the transcription deficient phenotype of H1(-) virions is due, in part, to hyperphosphorylation of A7. That A7 is located in cores and H1 in LBs within
MVs 54 further suggests that activation of virion transcriptional competence must occur in IVs when H1, A7, and other factors required for early transcription are within a single virion compartment ( Fig. 5 ).
Our results reveal the underlying complexity and implicit spatial/temporal regulation of the F10/H1 signaling network required to assure the formation of infectious poxvirus particles. Thus using mutant viruses in combination with proteotype information we have demonstrated that one can go beyond virus genotype-phenotype relationships to define viral signaling networks, uncover masked phenotypes, and define new links between mutant virus phenotypes and their causal proteotypes.
Experimental Procedures
Antibodies and drugs
Mouse anti-HA MAb HA.11 (16B12) was purchased from Covance (Princeton, NJ, USA). IPTG. Recombinant VACV strain viA7L mCherry-A4 was generated based on strain viA7L by replacing the endogenous A4L gene with the mCherry-A4L fusion as described before 55, 56 . Recombinant viA7 mCherry-A4 was identified based on plaque fluorescence and purified by at least two rounds of plaque purification. MV particles were produced in BSC-40 cells and purified from cytoplasmic lysates as described elsewhere 57 . 
Lysis and tryptic digest
Phosphorylation site identification and localization
SEQUEST (v27.0) 59 was used to search fragment ion spectra for a match to semi-tryptic peptides with up to two missed cleavage sites from a protein database, which was composed of human proteins (SwissProt, v57.15), Vaccinia virus proteins (UniProt, strain Western Reserve) 63 , various common contaminants, as well as sequence-reversed decoy proteins. The precursor ion mass tolerance was set to 0.05
Da. Carbamidomethylation was set as a fixed modification on all cysteines and phosphorylation of serines, threonines and tyrosines as well as oxidation of methionines was considered as optional modification. Resulting peptide-spectrum matches (PSMs)
were statistically validated and filtered for a minimum probability of 0.9 using PeptideProphet (TPP v4.6.2) 60 . Phosphorylated PSMs were further assessed using PTMprophet (TPP v4.6.2) 64 computing a localization probability for any of the serines, threonines and tyrosines within a peptide sequence. Based on these probabilities we pinned down phosphorylations to actual sites as follows. For a PSM where a phosphorylation was localized to a site with a probability of 0.9 or higher, this site was considered phosphorylated. Phosphorylation sites with a probability of 0.1 or lower were discarded. For a PSM with phosphorylation localization probabilities between 0.1 and 0.9, the following heuristic was used to derive the phosphorylation site: For each phosphorylation site its maximum localization probability across all samples was calculated. If there was only one site with a sample-wide probability of 0.9 or higher, this site was considered phosphorylated. If there were multiple sites with sample-wide probabilities of 0.9 or higher, those sites were combined to a "shared phosphorylation".
Also, if none of the sites had a sample-wide probabilities of 0.9 or higher, the sites were combined to a "shared phosphorylation" and reported with the separator "|". This procedure was repeatedly applied for multiply phosphorylated PSMs.
Phosphorylation site quantification and differential expression analysis
Peptides were quantified on MS1 level using Skyline (version 1.3) 65 . The integrated areas of a peptide's isotopic peaks were summed up and peptides with ambiguous PTM sites were merged if they had a retention time overlap of more than 50%.
Phosphorylation site localization was determined as described above. MSstats (version 1.0) 61 was used to determine statistically significant differentially expressed phosphorylation sites by building an ANOVA model for each site, based on all quantified peptides featuring this site. Shared phosphorylation sites as well as protein groups were used in each site/group repeatedly. Tests for differential expression were performed for each site and each pair of conditions and resulting p-values were corrected for multiple testing with Benjamini-Hochberg method 62 .
Immunofluorescence and electron microscopy
BSC-40 cells were seeded onto 13 mm glass coverslips in 24-well plates, infected with strain viA7 mCherry-A4 at an MOI of 4 as described in the transient complementation section, and transfected with 800 ng plasmid and 3 ul Lipofectamine2000. For immunofluorescence staining, cells were fixed in 4% formaldehyde, permeabilized with 0.5% Triton X-100, and stained with primary anti-HA (1:1000) and
AlexaFluor-647-coupled secondary antibody (1:1000 
Transient complementation assay
VACV genes F10L, I7L, L3L, I8R, and A7L and their endogenous promoters were amplified from VACV genomic DNA. C-terminal HA-tags were introduced by two consecutive rounds of PCR and the products cloned into pBSIIKS using the primers and enzymes listed in Supplementary Table S5 . Amino acid changes were introduced using quickchange site-directed mutagenesis (Agilent Technologies, Santa Clara, CA, USA). S885 S887 S172 S11|S12 S11|S12|Y13 S49|T51 S150 T82 T82|S85 S85 S88 S32 S167 S197 T19|T20|T30|(a) S42 S37 S14|S15 
Rifampicin release assay
Proteomics data deposition
Figure Legends
T16 S235 A50R S168 F10L S7|S8|Y11 S52 S52|S53 S53 G3L S110 S229 S261 T304|S305|T308|(b) S109 S260 I7L S134 L1R T238|S239
